Literature DB >> 2118698

A low-incidence red cell antigen JAL associated with two unusual Rh gene complexes.

C Lomas1, J Poole, N Salaru, M Redman, K Kirkley, M Moulds, J McCreary, G S Nicholson, H Hustinx, C Green.   

Abstract

A multilaboratory investigation during several years has identified a low incidence antigen JAL on the red cells of 7 propositi. JAL appears to be associated with two unusual Rh complexes, one of which produces a depressed C antigen and the other a depressed c antigen. Family studies strongly suggest that the JAL antigen is encoded by the RH locus. Anti-JAL has been implicated in haemolytic disease of the newborn and is thus considered to be a clinically significant antibody.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2118698     DOI： 10.1111/j.1423-0410.1990.tb02112.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


  4 in total

1.  Red cells from the original JAL+ proband are also DAK+ and STEM+.

Authors:  K Hue-Roye; M E Reid; C M Westhoff; C Lomas-Francis
Journal:  Vox Sang       Date:  2011-04-08       Impact factor: 2.144

2.  The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.

Authors:  Connie M Westhoff; Sunitha Vege; Dwane Wylie; Pam Nickle; Christine Lomas-Francis; Kim Hue-Roye; Marion E Reid
Journal:  Transfusion       Date:  2008-12-23       Impact factor: 3.157

3.  Alloanti-c in a c-positive, JAL-positive patient.

Authors:  J Ong; P S Walker; E Schmulbach; J R Storry; S Vege; C Westhoff; C Lomas-Francis; M E Reid
Journal:  Vox Sang       Date:  2008-12-05       Impact factor: 2.144

4.  JAL (RH48) blood group antigen: serologic observations.

Authors:  Christine Lomas-Francis; Denden Alcantara; Connie Westhoff; Joan Uehlinger; Marilia Valvasori; Lillian Castilho; Marion E Reid
Journal:  Transfusion       Date:  2008-12-15       Impact factor: 3.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.